Weaver C. Barksdale & Associates’s Synovus SNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$8K Sell
160
-4
-2% -$189 0.01% 322
2017
Q3
$8K Buy
164
+5
+3% +$217 0.01% 317
2017
Q2
$7K Sell
159
-17
-10% -$714 0.01% 333
2017
Q1
$7K Buy
176
+20
+13% +$834 0.01% 341
2016
Q4
$6K Sell
156
-9
-5% -$331 0.01% 361
2016
Q3
$5K Buy
165
+5
+3% +$157 0.01% 384
2016
Q2
$5K Buy
160
+21
+15% +$638 0.01% 362
2016
Q1
$4K Hold
139
﹤0.01% 416
2015
Q4
$5K Sell
139
-9
-6% -$287 ﹤0.01% 383
2015
Q3
$4K Sell
148
-18
-11% -$552 ﹤0.01% 417
2015
Q2
$5K Hold
166
﹤0.01% 392
2015
Q1
$5K Sell
166
-25
-13% -$678 ﹤0.01% 393
2014
Q4
$5K Sell
191
-22
-10% -$556 ﹤0.01% 384
2014
Q3
$5K Hold
213
﹤0.01% 376
2014
Q2
$5K Sell
213
-140
-40% -$3.26K ﹤0.01% 389
2014
Q1
$8K Sell
353
-126
-26% -$3.06K 0.01% 304
2013
Q4
$12K Sell
479
-13
-3% -$306 0.01% 243
2013
Q3
$11K Sell
492
-41
-8% -$934 0.01% 254
2013
Q2
$11K Buy
+533
New +$10.1K 0.01% 254

Other funds holding SNV

Weaver C. Barksdale & Associates's SNV Position: Q4 2017 in Review

Weaver C. Barksdale & Associates reduced its Synovus (SNV) stake by 2.4% in Q4 2017, selling an estimated $189 and leaving 160 shares worth $8K. The position accounts for 0.01% of the portfolio, ranked #322.

Weaver C. Barksdale & Associates first reported a position in SNV in Q2 2013 and has held it in 19 quarters since. The position peaked at $12K in Q4 2013. 333 funds tracked by Wall St. Rank hold SNV as of Q4 2017.

  • Weaver C. Barksdale & Associates held 160 shares of Synovus worth $8K as of Q4 2017.
  • Weaver C. Barksdale & Associates sold 4 Synovus shares in Q4 2017, an estimated $189.
  • Synovus made up 0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #322 holding.
  • Weaver C. Barksdale & Associates first reported a position in Synovus in Q2 2013 and has held it in 19 quarters since.
  • Weaver C. Barksdale & Associates's Synovus position peaked at $12K in Q4 2013.
  • 333 funds tracked by Wall St. Rank held Synovus as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.